Teen exercise may reduce risk of dying from cancer during adulthood in women
the ONA take:
The amount of exercise women performed during their teenage years may have an impact on their risk of dying from cancer or other causes as adults, according to a new study published in the journal Cancer Epidemiology, Biomarkers & Prevention.
For the study, researchers analyzed data from the Shanghai Women's Health Study that included and followed 75,000 women in Shanghai, China for over a decade. Data included lifestyle behaviors and mortality outcomes.
Results showed that women who had reported participating in exercise had reduced risks of death from cancer and other causes compared with those who had not exercised. Specifically, women who exercised for 1.33 hours a week or less were 16% less likely to have died from cancer than their non-exercising counterparts.
Researchers also found that women who participated in team sports as an adolescent had a 14% lower risk of death from cancer than those who did not participate in team sports.
The findings ultimately contribute to the growing evidence that exercise participation contributes to a reduced risk of dying from certain cancers.
Exercise women performed duringExercise women performed during their teenage years may have an impac their teenage years may have an impact on their risk of dying from cancer or other causes as adults
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|